The latest quarterly capex is −$5.26 Million with a QoQ Growth of -36.71%. Capital Expenditures (CapEx) represents spending on physical assets like property, plant, equipment, and technology infrastructure. It's the investment in the company's future productive capacity.
Q2 FY2026 (2026-06-30).
Reported quarterly capital expenditures; no daily interpolation. Q2 FY2026 (2026-06-30): $-5.26M.
−$5.26M
−$5.26 Million
Q2 FY2026 · 2026-06-30
-36.71%
vs. −$3.85M prior quarter
22
Quarters of data available
| Period | CapEx | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | −$5.26M | -36.71% | -3.50% |
| Q1 FY2026Period end 2026-03-31 | −$3.85M | -4.11% | -0.10% |
| Q4 FY2025Period end 2025-12-31 | −$3.70M | +21.91% | -9.64% |
| Q3 FY2025Period end 2025-09-30 | −$4.73M | +6.88% | -107.18% |
| Q2 FY2025Period end 2025-06-30 | −$5.08M | -32.22% | -165.21% |
| Q1 FY2025Period end 2025-03-31 | −$3.85M | -14.03% | -121.36% |
| Q4 FY2024Period end 2024-12-31 | −$3.37M | -47.57% | -44.97% |
| Q3 FY2024Period end 2024-09-30 | −$2.29M | -19.20% | -13.51% |
| Q2 FY2024Period end 2024-06-30 | −$1.92M | -10.36% | +38.89% |
| Q1 FY2024Period end 2024-03-31 | −$1.74M | +25.32% | +15.31% |
| Q4 FY2023Period end 2023-12-31 | −$2.33M | -15.55% | +0.47% |
| Q3 FY2023Period end 2023-09-30 | −$2.01M | +35.83% | +78.05% |
| Q2 FY2023Period end 2023-06-30 | −$3.14M | -52.95% | +9.78% |
| Q1 FY2023Period end 2023-03-31 | −$2.05M | +12.24% | +44.04% |
| Q4 FY2022Period end 2022-12-31 | −$2.34M | +74.51% | N/A |
| Q3 FY2022Period end 2022-09-30 | −$9.17M | -163.70% | -1486.33% |
| Q2 FY2022Period end 2022-06-30 | −$3.48M | +5.13% | -678.72% |
| Q1 FY2022Period end 2022-03-31 | −$3.67M | N/A | -720.83% |
| Q4 FY2021Period end 2021-12-31 | −$231.00K | +60.03% | N/A |
| Q3 FY2021Period end 2021-09-30 | −$578.00K | -29.45% | N/A |
| Q2 FY2021Period end 2021-06-30 | −$446.50K | 0.00% | N/A |
| Q1 FY2021Period end 2021-03-31 | −$446.50K | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
